CD276 and urothelial carcinoma: Examining the pathological grades, we discovered a pronounced elevation of CD276 in high-grade urothelial carcinoma compared to its lower expression in its low-grade counterparts, with this variation being statistically significant (Figure 2C, p<0.001).